AMERICAN ACADEMY OF PEDIATRICS |
Health Supervision for Children with Sickle Cell Disease
Sickle cell disease (SCD) is a group of complex genetic disorders with multisystem manifestations. This statement provides pediatricians in primary care and subspecialty practice with an overview of the genetics, diagnosis, clinical manifestations, and treatment of SCD. Specialized comprehensive medical care decreases morbidity and mortality during childhood. The provision of comprehensive care is a time-intensive endeavor that includes ongoing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, psychosocial care, and genetic counseling. Timely and appropriate treatment of acute illness is critical, because life-threatening complications develop rapidly. It is essential that every child with SCD receive comprehensive care that is coordinated through a medical home with appropriate expertise.
Key Words: SCD, sickle cell disease • HbS, sickle hemoglobin • HbF, fetal hemoglobin • HbSS, sickle cell anemia • HbSC, sickle-hemoglobin C disease • HbF, fetal hemoglobin • HPLC, high-performance liquid chromatography • AAP, American Academy of Pediatrics • CNS, central nervous system • CBC, complete blood cell • TCD, transcranial Doppler • HbA2, hemoglobin A2 • MCV, mean corpuscular volume • Hib, Haemophilus influenzae type b • TIA, transient ischemic attack
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Statement of reaffirmation:
- AAP Publications Retired and Reaffirmed
Pediatrics 117: 1846-1847.[Full Text]
This article has been cited by other articles:
|
|
 |
|
  D. G. Bundy, J. J. Strouse, J. F. Casella, and M. R. Miller Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease Pediatrics, February 1, 2010; 125(2): 234 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Armstrong-Wells, B. Grimes, S. Sidney, D. Kronish, S. C. Shiboski, R. J. Adams, and H. J. Fullerton Utilization of TCD screening for primary stroke prevention in children with sickle cell disease Neurology, April 14, 2009; 72(15): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Grosse, M. S. Schechter, R. Kulkarni, M. A. Lloyd-Puryear, B. Strickland, and E. Trevathan Models of Comprehensive Multidisciplinary Care for Individuals in the United States With Genetic Disorders Pediatrics, January 1, 2009; 123(1): 407 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Pashankar, J. Carbonella, A. Bazzy-Asaad, and A. Friedman Prevalence and Risk Factors of Elevated Pulmonary Artery Pressures in Children With Sickle Cell Disease Pediatrics, April 1, 2008; 121(4): 777 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Schatz, C. B. McClellan, E. S. Puffer, K. Johnson, and C. W. Roberts Neurodevelopmental Screening in Toddlers and Early Preschoolers With Sickle Cell Disease J Child Neurol, January 1, 2008; 23(1): 44 - 50. [Abstract] [PDF]
|
|
|
|
|
|
M. Mazumdar, M. M. Heeney, C. M. Sox, and T. A. Lieu Preventing Stroke Among Children With Sickle Cell Anemia: An Analysis of Strategies That Involve Transcranial Doppler Testing and Chronic Transfusion Pediatrics, October 1, 2007; 120(4): e1107 - e1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Roberts and M. de Montalembert Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe Haematologica, July 1, 2007; 92(7): 865 - 871. [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Quinn, E. P. Shull, N. Ahmad, N. J. Lee, Z. R. Rogers, and G. R. Buchanan Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia Blood, January 1, 2007; 109(1): 40 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Kaye and and the Committee on Genetics Newborn Screening Fact Sheets Pediatrics, September 1, 2006; 118(3): e934 - e963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Smith, S. O. Oyeku, C. Homer, and B. Zuckerman Sickle Cell Disease: A Question of Equity and Quality Pediatrics, May 1, 2006; 117(5): 1763 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Villella Improved Survival for Children with Sickle Cell Disease AAP Grand Rounds, October 1, 2004; 12(4): 41 - 42. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Stegenga, P. Ward-Smith, P. S. Hinds, J. A. Routhieaux, and G. M. Woods Quality of Life Among Children With Sickle Cell Disease Receiving Chronic Transfusion Therapy Journal of Pediatric Oncology Nursing, July 1, 2004; 21(4): 207 - 213. [Abstract] [PDF]
|
|
|
|
|
|
S. L. Bratton Death, Pulmonary Hypertension, and Sickle Cell Disease AAP Grand Rounds, June 1, 2004; 11(6): 63 - 64. [Full Text] [PDF]
|
|
|
|
|
|
C. T. Quinn, Z. R. Rogers, and G. R. Buchanan Survival of children with sickle cell disease Blood, June 1, 2004; 103(11): 4023 - 4027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Claster and E. P Vichinsky Managing sickle cell disease BMJ, November 15, 2003; 327(7424): 1151 - 1155. [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Wilson, L. Krishnamurti, and D. Kamat Management of Sickle Cell Disease in Primary Care Clinical Pediatrics, November 1, 2003; 42(9): 753 - 761. [PDF]
|
|
|
|
 |
|
 C. M. Sox, W. O. Cooper, T. D. Koepsell, D. L. DiGiuseppe, and D. A. Christakis Provision of Pneumococcal Prophylaxis for Publicly Insured Children With Sickle Cell Disease JAMA, August 27, 2003; 290(8): 1057 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sox, P. A. Lane, G. R. Buchanan, F. Desposito, C. H. Pegelow, E. P. Vichinsky, D. L. Wethers, and G. M. Woods Health Supervision for Children With Sickle Cell Disease Pediatrics, March 1, 2003; 111(3): 710 - 711. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Walters, A. W. Nienhuis, and E. Vichinsky Novel Therapeutic Approaches in Sickle Cell Disease Hematology, January 1, 2002; 2002(1): 10 - 34. [Abstract] [Full Text]
|
|
